Literature DB >> 7103626

Bacteremias and fungemias in oncologic patients with central venous catheters: changing spectrum of infection.

J N Lowder, H M Lazarus, R H Herzig.   

Abstract

Ninety central venous catheters were inserted into 80 patients undergoing therapy for malignant neoplasms. Bacteremia and fungemia occurred in 18 of 41 treatment courses in patients with acute leukemia and in nine of 55 treatment courses in patients with solid tumors and lymphomas. Although gram-negative organisms accounted for nine (33%) cases of infection, the majority of disseminated infections were caused by gram-positive organisms (12 [45%] cases) or fungi (six [22%] cases). Central venous catheters may be helpful in the treatment of patients undergoing intensive therapy with cytotoxic agents, but the shift in-spectrum of infection to gram-positive bacteremias in patients with these catheters compared with patients treated using peripheral vein access must be appreciated.

Entities:  

Mesh:

Year:  1982        PMID: 7103626

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  18 in total

1.  Changes in the spectrum of organisms causing bacteremia and fungemia in immunocompromised patients due to venous access devices.

Authors:  T E Kiehn; D Armstrong
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-12       Impact factor: 3.267

Review 2.  Supportive therapy in management of leukemias.

Authors:  V P Choudhry; N Desai
Journal:  Indian J Pediatr       Date:  1993 Mar-Apr       Impact factor: 1.967

3.  Superinfections during antimicrobial treatment with betalactam-aminoglycoside combinations in neutropenic patients with hematologic malignancies.

Authors:  P Serra; C Santini; M Venditti; F Mandelli; P Martino
Journal:  Infection       Date:  1985       Impact factor: 3.553

Review 4.  Use of cephalosporins in the immunologically compromised patient.

Authors:  A C Newland; H Gaya
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 5.  Bacteremia and fungemia in the immunocompromised patient.

Authors:  T E Kiehn
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-09       Impact factor: 3.267

6.  Effect of antimicrobial and antineoplastic drugs on the uptake of fluconazole by human neutrophils and tissue culture cells.

Authors:  I García; A Pascual; C Conejo; J Salvador; E J Perea
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-12       Impact factor: 3.267

7.  Incidence of catheter-associated gram-negative bacteremia in children with short bowel syndrome.

Authors:  P A Piedra; D M Dryja; L J LaScolea
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

8.  Association of slime with pathogenicity of coagulase-negative staphylococci causing nosocomial septicemia.

Authors:  M A Ishak; D H Gröschel; G L Mandell; R P Wenzel
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

9.  Changing causes of septicaemia in paediatric oncology patients: effect of imipenem use.

Authors:  J W Gray; S J Pedler; A W Craft; J Kernahan; K P Windebank; A D Pearson
Journal:  Eur J Pediatr       Date:  1994-02       Impact factor: 3.183

10.  Central venous catheter infections in pediatric patients--in a community hospital.

Authors:  A Kumar; S S Brar; D L Murray; I Leader; R Gera; R Kulkarni
Journal:  Infection       Date:  1988 Mar-Apr       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.